The Impact of DXA-Based Body Composition Phenotypes on the All-cause Mortality Among the US Cancer Survivors

West China Hospital0 sites1,500 target enrollmentJanuary 1, 1999

ConditionsBody Composition Morality Cancer Survivor

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Body Composition
Sponsor: West China Hospital
Enrollment: 1500
Primary Endpoint: Rate of all-cause mortality
Status: Completed
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

This study aims to evaluate the association between body composition and mortality risk among the US population based on data from the National Health and Nutrition Examination Survey (NHANES), a nationally representative cohort.

Registry

clinicaltrials.gov

Start Date

January 1, 1999

End Date

December 31, 2018

Last Updated

last year

Study Type

Observational

Sex

All

Investigators

Sponsor

West China Hospital

Responsible Party

Principal Investigator

Lei Liu

Director

West China Hospital

Eligibility Criteria

Inclusion Criteria

•Participants with cancer diagnosis beyond 18 years old.

Exclusion Criteria

•Participants with missing cancer investigations and incomplete DXA body composition data were excluded from the study.

Outcomes

Primary Outcomes

Rate of all-cause mortality

Time Frame: Jan 1 1999 to Dec 31 2019

To evaluate the association between muscle mass index (MMI, muscle mass and height will be combined to report MMI in kg/m\^2) and all-cause mortality among cancer survivors.